Relief Therapeutics Advances Publication of 2025 Half-Year Report
-
Indonesia, Peru strike trade agreement as leaders meet
-
Japan boxing to hold emergency meeting following deaths
-
Chinese vessels collide while pursuing Philippine boat in South China Sea: Manila
-
Australia to recognise Palestinian state
-
Liverpool spend big to hold off Arsenal, City in Premier League title fight
-
Four days left to square the circle on global plastic pollution treaty
-
Alcaraz battles as Shelton, Zverev race into Cincinnati third round
-
'My boss raped me': Japanese prosecutor's fight for justice
-
Asian markets waver to start key week for trade, US data
-
Marcos says Philippines would be dragged 'kicking and screaming' into Taiwan war
-
China's Gen Z women embrace centuries-old script
-
With poetry and chants, Omanis strive to preserve ancient language
-
Australia women's rugby team lose trump card Caslick for World Cup
-
New tensions trouble small town America in Trump's second term
-
Al Jazeera says 5 journalists killed in Israeli strike in Gaza
-
Alcaraz battles through, Shelton advances in Cincinnati
-
Relief Therapeutics Advances Publication of 2025 Half-Year Report
-
31 Concept to Debut Patent-Pending Technology at ISS Asia 2025 in Singapore
-
Liberty Home Loans Offer Flexible Support as Housing Incentives Roll Out
-
Rose tops Spaun in playoff to win PGA St. Jude as Fleetwood falters again
-
Pioneering MLB umpire Pawol debuts behind plate in Braves win
-
West Indies level ODI series with Pakistan as Chase stars
-
Spain's Alex Palou wins third consecutive IndyCar season title
-
Barcelona look smooth in Como demolition as Ter Stegen buries hatchet
-
Erratic Alcaraz battles through in Cincinnati opening match
-
One killed, dozens injured, as quake hits western Turkey
-
Burmester wins playoff to capture LIV Golf Chicago crown
-
Course owner Trump hails Forrest's 'brilliant' Scottish Championship win
-
Eight dead in shooting outside Ecuador nightclub: police
-
NASCAR driver breaks collarbone in fall as he celebrates win
-
Swiatek advances by walkover into Cincinnati fourth round
-
Hundreds march in London against UK recognising a Palestinian state
-
Moscow strikes kill six in Ukraine; refineries hit in Russia
-
Firefighters bring huge blaze in France under control
-
Swiss pilot takes big step closer to solar plane altitude record
-
Slot seeks Liverpool balance for Premier League defence
-
Mali arrests dozens of soldiers over alleged bid to topple junta
-
After busy first 100 days, Germany's Merz faces discord at home
-
'Weapons' battles to top of North American box office
-
Israel's Gaza plan risks 'another calamity,' UN official warns
-
Local hero Forrest wins Scottish Championship golf
-
Trump says to move homeless people 'far' from Washington
-
New-look Liverpool humbled by Crystal Palace in Community Shield
-
Italy's Mount Vesuvius closed to tourists over wildfire
-
Europe pushes for Ukraine role in Trump-Putin talks
-
Israel's Gaza plan risks 'another calamity': UN official
-
Israel PM says new plan for Gaza 'best way to end the war'
-
Indigenous communities plead for action at plastic pollution talks
-
Power-packed David slams 83 as Australia beat South Africa in 1st T20
-
Italy's Mount Vesuvius closed to tourists as wildfire rages
NYSE - LSE
| RBGPF | 1.7% | 73.08 | $ | |
| SCU | 0% | 12.72 | $ | |
| SCS | -0.76% | 15.88 | $ | |
| NGG | -1.51% | 71.01 | $ | |
| RELX | -2.2% | 48 | $ | |
| RIO | 1.76% | 61.86 | $ | |
| GSK | 0.58% | 37.8 | $ | |
| CMSD | 0.25% | 23.58 | $ | |
| RYCEF | -0.14% | 14.42 | $ | |
| CMSC | 0.39% | 23.05 | $ | |
| BP | -0.15% | 34.14 | $ | |
| BTI | 0.96% | 57.24 | $ | |
| BCC | -1.34% | 82.09 | $ | |
| JRI | 0.19% | 13.435 | $ | |
| AZN | -0.71% | 73.535 | $ | |
| VOD | 0.88% | 11.36 | $ | |
| BCE | 2.34% | 24.35 | $ |
Relief Therapeutics Advances Publication of 2025 Half-Year Report
GENEVA, SWITZERLAND / ACCESS Newswire / August 11, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that it has advanced the publication date of its 2025 half-year report. Originally scheduled for release on August 27, 2025, the report will now be published on August 14, 2025, ahead of market opening.
The change in publication date is due to the Company's anticipated early completion of the report. The half-year report, which will include a shareholder update and interim financial statements, will be available on Relief's website at the time of publication.
ABOUT RELIEF
Relief is a commercial-stage biopharmaceutical company dedicated to advancing treatment paradigms and improving the lives of patients with rare and debilitating diseases. With core expertise in drug delivery systems and drug repurposing, Relief's clinical pipeline includes innovative treatments designed to address critical unmet medical needs in rare dermatological, metabolic and respiratory conditions. The Company has also successfully brought several approved products to market through licensing and distribution partnerships. Headquartered in Geneva, Relief is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY. For more information, visit www.relieftherapeutics.com.
CONTACT
RELIEF THERAPEUTICS Holding SA
Jeremy Meinen
Chief Financial Officer
[email protected]
SOURCE: Relief Therapeutics Holding SA
View the original press release on ACCESS Newswire
D.Cunningha--AMWN